Running Clinical Trials

Sign up for Good Clinical Practice/Human Subject Protection e-mail updates

 

The U.S. Food & Drug Administration (FDA) recently redesigned the FDA Web site. As a result, the Good Clinical Practice Program was moved.

Additionally, some Web links (URLs) embedded within Guidance documents, Rules, and other documents are no longer valid. If you find a link that does not work, please try searching for the document using the document title. For more assistance, go to Contact FDA

We apologize for any inconvenience this redesign might have caused.

Good Clinical Practice Program Mission

The Good Clinical Practice Program is the focal point within FDA for Good Clinical Practice issues arising in human research trials regulated by FDA. In relation to Good Clinical Practice, the Good Clinical Practice Program:

• Coordinates FDA policies
• Contributes to leadership and direction through participation in FDA's Human Subject Protection/Bioresearch Monitoring Council
• Coordinates FDA's Bioresearch Monitoring program with respect to clinical trials, working together with FDA's Office of Regulatory Affairs (ORA)
• Contributes to international Good Clinical Practice harmonization activities
• Plans and conducts training and outreach programs
• Serves as a liaison with the HHS Office for Human Research Protection (OHRP) and other federal agencies and external stakeholders committed to the protection of human research participants